Literature DB >> 25933988

Correcting for Brain Swelling's Effects on Infarct Volume Calculation After Middle Cerebral Artery Occlusion in Rats.

Devin W McBride1, Damon Klebe, Jiping Tang, John H Zhang.   

Abstract

Evaluating infarct volume is the primary outcome for experimental ischemic stroke studies and is a major factor in determining translation of a drug into clinical trials. Numerous algorithms are available for evaluating this critical value, but a major limitation of current algorithms is that brain swelling is not appropriately considered. The model by Lin et al. is widely used, but overestimates swelling within the infarction, yielding infarct volumes which do not reflect the true infarct size. Herein, a new infarct volume algorithm is developed to minimize the effects of both peri-infarct and infarct core swelling on infarct volume measurement. 2,3,5-Triphenyl-2H-tetrazolium chloride-stained brain tissue of adult rats subjected to middle cerebral artery occlusion was used for infarct volume analysis. When both peri-infarct swelling and infarction core swelling are removed from infarct volume calculations, such as accomplished by our algorithm, larger infarct volumes are estimated than those of Lin et al.'s algorithm. Furthermore, the infarct volume difference between the two algorithms is the greatest for small infarcts (<10% of brain volume) when peri-infarct swelling is the greatest. Finally, using data from four published studies, our algorithm is compared to Lin et al.'s algorithm. Our algorithm offers a more reliable estimation of the infarct volume after ischemic brain injury, and thus may provide the foundation for comparing infarct volumes between experimental studies and standardizing infarct volume quantification to aid in the selection of the best candidates for clinical trials.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25933988      PMCID: PMC4765329          DOI: 10.1007/s12975-015-0400-3

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  48 in total

1.  Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour.

Authors:  R G Robinson; W J Shoemaker; M Schlumpf; T Valk; F E Bloom
Journal:  Nature       Date:  1975-05-22       Impact factor: 49.962

2.  A pilot study of normobaric oxygen therapy in acute ischemic stroke.

Authors:  Aneesh B Singhal; Thomas Benner; Luca Roccatagliata; Walter J Koroshetz; Pamela W Schaefer; Eng H Lo; Ferdinando S Buonanno; R Gilberto Gonzalez; A Gregory Sorensen
Journal:  Stroke       Date:  2005-03-10       Impact factor: 7.914

3.  Experimental cerebral infarction: retro-orbital, extradural approach for occluding the middle cerebral artery.

Authors:  T M Sundt; A G Waltz
Journal:  Mayo Clin Proc       Date:  1966-03       Impact factor: 7.616

4.  Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia.

Authors:  T Kondo; A G Reaume; T T Huang; E Carlson; K Murakami; S F Chen; E K Hoffman; R W Scott; C J Epstein; P H Chan
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 5.  Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema.

Authors:  Arjun Khanna; Kristopher T Kahle; Brian P Walcott; Volodymyr Gerzanich; J Marc Simard
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

6.  Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques.

Authors:  Kudret Türeyen; Raghu Vemuganti; Kurt A Sailor; Robert J Dempsey
Journal:  J Neurosci Methods       Date:  2004-10-30       Impact factor: 2.390

7.  A pilot study of hyperbaric oxygen in the treatment of human stroke.

Authors:  D C Anderson; A G Bottini; W M Jagiella; B Westphal; S Ford; G L Rockswold; R B Loewenson
Journal:  Stroke       Date:  1991-09       Impact factor: 7.914

8.  Rat middle cerebral artery occlusion using an intraluminal thread technique.

Authors:  S Kawamura; N Yasui; M Shirasawa; H Fukasawa
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Brain calcium content in ischemic infarction.

Authors:  S T Chen; C Y Hsu; E L Hogan; H Y Juan; N L Banik; J D Balentine
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

10.  BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage.

Authors:  M J Leach; J H Swan; D Eisenthal; M Dopson; M Nobbs
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

View more
  28 in total

1.  Differential effects of hypothermia on neurovascular unit determine protective or toxic results: Toward optimized therapeutic hypothermia.

Authors:  Patrick D Lyden; Jessica Lamb; Shweta Kothari; Shahed Toossi; Paul Boitano; Padmesh S Rajput
Journal:  J Cereb Blood Flow Metab       Date:  2018-11-21       Impact factor: 6.200

2.  Intranasal Dexamethasone Reduces Mortality and Brain Damage in a Mouse Experimental Ischemic Stroke Model.

Authors:  Alejandro Espinosa; Gabriela Meneses; Anahí Chavarría; Raúl Mancilla; José Pedraza-Chaverri; Agnes Fleury; Brandon Bárcena; Ivan N Pérez-Osorio; Hugo Besedovsky; Antonio Arauz; Gladis Fragoso; Edda Sciutto
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

3.  Cerebrospinal fluid influx drives acute ischemic tissue swelling.

Authors:  Humberto Mestre; Ting Du; Amanda M Sweeney; Guojun Liu; Andrew J Samson; Weiguo Peng; Kristian Nygaard Mortensen; Frederik Filip Stæger; Peter A R Bork; Logan Bashford; Edna R Toro; Jeffrey Tithof; Douglas H Kelley; John H Thomas; Poul G Hjorth; Erik A Martens; Rupal I Mehta; Orestes Solis; Pablo Blinder; David Kleinfeld; Hajime Hirase; Yuki Mori; Maiken Nedergaard
Journal:  Science       Date:  2020-01-30       Impact factor: 47.728

4.  Embracing Biological and Methodological Variance in a New Approach to Pre-Clinical Stroke Testing.

Authors:  Thomas A Kent; Pitchaiah Mandava
Journal:  Transl Stroke Res       Date:  2016-03-28       Impact factor: 6.829

5.  Delayed Recanalization Promotes Functional Recovery in Rats Following Permanent Middle Cerebral Artery Occlusion.

Authors:  Devin William McBride; Guangyong Wu; Derek Nowrangi; Jerry J Flores; Liang Hui; Paul R Krafft; John H Zhang
Journal:  Transl Stroke Res       Date:  2018-01-21       Impact factor: 6.829

6.  Adrenergic receptor antagonism induces neuroprotection and facilitates recovery from acute ischemic stroke.

Authors:  Hiromu Monai; Xiaowen Wang; Kazuko Yahagi; Nanhong Lou; Humberto Mestre; Qiwu Xu; Yoichiro Abe; Masato Yasui; Youichi Iwai; Maiken Nedergaard; Hajime Hirase
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

7.  Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia/reperfusion injury via their antiglycemic effect.

Authors:  Hossein Ahmadi-Eslamloo; Gholam Abbas Dehghani; Seyed Mostafa Shid Moosavi
Journal:  Metab Brain Dis       Date:  2017-11-19       Impact factor: 3.584

Review 8.  SUR1-TRPM4 channels, not KATP, mediate brain swelling following cerebral ischemia.

Authors:  Seung Kyoon Woo; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Volodymyr Gerzanich; J Marc Simard
Journal:  Neurosci Lett       Date:  2019-12-31       Impact factor: 3.046

9.  Crotalus atrox disintegrin reduces hemorrhagic transformation by attenuating matrix metalloproteinase-9 activity after middle cerebral artery occlusion in hyperglycemic male rats.

Authors:  Devin W McBride; Eric C K Gren; Wayne Kelln; William K Hayes; John H Zhang
Journal:  J Neurosci Res       Date:  2018-09-22       Impact factor: 4.164

10.  A Brief Review of Edema-Adjusted Infarct Volume Measurement Techniques for Rodent Focal Cerebral Ischemia Models with Practical Recommendations.

Authors:  Cyrus Nouraee; Marc Fisher; Mario Di Napoli; Pascal Salazar; Tracy D Farr; Alibay Jafarli; Afshin A Divani
Journal:  J Vasc Interv Neurol       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.